BIEL patent (pending) BLOCKBUSTER! BIEL BioElectr
Post# of 94181
(Total Views: 36)
Posted On: 02/21/2025 11:46:50 PM
BIEL patent (pending) BLOCKBUSTER!
BIEL BioElectronics Corporation Announces Utility Patent Application Filing
Non-Invasive Device Addresses the Treatment of Chronic Inflammation
FREDERICK, MD - (NewMediaWire) - May 21, 2024 - BioElectronics Corporation(BIEL) Technology applied to the vagal nerves of dogs diagnosed with osteoarthritis resulted in significant reductions in systemic discomfort.
Chronic inflammation poses a significant challenge to modern medicine. While few effective interventions exist, management of the condition often involves removing inflammatory triggers through dietary or lifestyle changes. Additionally, anti-inflammatory medications are commonly used, but their chronic use is costly and associated with significant side effects.
A promising approach for addressing chronic inflammation emerged with the discovery of the inflammatory reflex. Similar to reflexes in the somatic nervous system, this reflex involves both the afferent (incoming) and efferent (outgoing) arms of the vagus nerve. Although vagus nerve stimulation has been shown to suppress pro-inflammatory cytokine levels in the periphery, traditional stimulation techniques are not suitable for chronic vagus nerve stimulation.
BioElectronics PSWT technology and device designs overcome this limitation, providing a convenient, economical, and highly effective alternative for treating chronic inflammation. Given that over one-third of Americans suffer from chronic, systemic inflammation, this development opens an enormous new market opportunity for BioElectronics(BIEL). The company plans to continue its efforts to provide clinical support and develop new designs for its product line.
BIEL BioElectronics Corporation Announces Utility Patent Application Filing
Non-Invasive Device Addresses the Treatment of Chronic Inflammation
FREDERICK, MD - (NewMediaWire) - May 21, 2024 - BioElectronics Corporation(BIEL) Technology applied to the vagal nerves of dogs diagnosed with osteoarthritis resulted in significant reductions in systemic discomfort.
Chronic inflammation poses a significant challenge to modern medicine. While few effective interventions exist, management of the condition often involves removing inflammatory triggers through dietary or lifestyle changes. Additionally, anti-inflammatory medications are commonly used, but their chronic use is costly and associated with significant side effects.
A promising approach for addressing chronic inflammation emerged with the discovery of the inflammatory reflex. Similar to reflexes in the somatic nervous system, this reflex involves both the afferent (incoming) and efferent (outgoing) arms of the vagus nerve. Although vagus nerve stimulation has been shown to suppress pro-inflammatory cytokine levels in the periphery, traditional stimulation techniques are not suitable for chronic vagus nerve stimulation.
BioElectronics PSWT technology and device designs overcome this limitation, providing a convenient, economical, and highly effective alternative for treating chronic inflammation. Given that over one-third of Americans suffer from chronic, systemic inflammation, this development opens an enormous new market opportunity for BioElectronics(BIEL). The company plans to continue its efforts to provide clinical support and develop new designs for its product line.
(0)
(0)Scroll down for more posts ▼